Brand Name |
Injection Trectabin (50 mg) |
Brand Constituents |
![]() ![]() |
Manufacturer Name |
RSM Kilitch Pharma Pvt Ltd |
Preparation Type |
Injection |
Standard Unit |
1 Vial |
Unit Price |
₹2750 |
Brand Package |
1 Vial |
Package Price |
₹2750 |
Trectabin (50 mg)
Post Review about Trectabin (50 mg) Click here to cancel reply.
Other Brands 100% Similar to Trectabin (50 mg)
Brand Name | Manufacturer | Unit/Price | Package unit/Price | Constituents/Unit |
---|---|---|---|---|
Injection Bactigelin (50 mg) | Lifecare Innovations Pvt. Ltd. | 1 Vial₹ 2915.00 | 1 Vial₹ 2915.00 |
![]() |
Injection Protigi (50 mg) | Progen Nutraceuticals Pvt Ltd | 1 Vial₹ 3230.00 | 1 Vial₹ 3230.00 |
![]() |
Injection Tigez (50 mg) | Lupin Laboratories Ltd. | 1 Vial₹ 1900.00 | 1 Vial₹ 1900.00 |
![]() |
Injection Tigaphar (50 mg) | Zyphars Pharmaceuticals Pvt Ltd | 1 Vial₹ 2790.00 | 1 Vial₹ 2790.00 |
![]() |
Injection Tigecycline (50 mg) | Natco Pharma Ltd | 1 Vial₹ 2990.00 | 1 Vial₹ 2990.00 |
![]() |
Injection Trectabin (50 mg) | RSM Kilitch Pharma Pvt Ltd | 1 Vial₹ 2750.00 | 1 Vial₹ 2750.00 |
![]() |
Injection Tize B (50 mg) | Health Biotech Pvt Ltd. | 1 Vial₹ 2900.00 | 1 Vial₹ 2900.00 |
![]() |
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.